Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients

NCT01099436 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: cyclophosphamide
DRUG: docetaxel
DRUG: doxorubicin hydrochloride
DRUG: zoledronic acid
PROCEDURE: neoadjuvant therapy

Sponsor

Borstkanker Onderzoek Groep

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]